Back to Search Start Over

"Isthmin Protein Therapeutics for the Treatment of Non-Alcoholic Fatty Liver Disease" in Patent Application Approval Process (USPTO 20240342244).

Source :
Drug Week; 11/8/2024, p498-498, 1p
Publication Year :
2024

Details

Language :
English
ISSN :
15316440
Database :
Supplemental Index
Journal :
Drug Week
Publication Type :
Periodical
Accession number :
180595059